HomeCompany NewsUS FDA approves Urogen's bladder cancer drug Company NewsHealthIsraelMiddle EastN2:BIODRGN2:CNCERN2:HECAN2:MEDREGN2:MRCHN2:PHMRN2:PUBLsubj:04002006subj:04016000subj:07000000subj:07001004subj:07013000subj:13019000 US FDA approves Urogen’s bladder cancer drug June 12, 2025 0 34 Share FacebookTwitterPinterestWhatsApp Signage is seen outside of FDA headquarters in White Oak, Maryland (Reuters) -The U.S. Food and Drug Administration has approved Urogen Pharma's drug to treat a type of bladder cancer, the regulator said on Thursday. (Reporting by Padmanabhan Ananthan and Kamal Choudhury in Bengaluru; Editing by Leroy Leo) Hi, I'm Reuters Share FacebookTwitterPinterestWhatsApp Previous articleUS sues New York over law blocking immigration enforcement near courtNext articleTunisia sentences prominent opposition figure Abir Moussi to two years in prison RELATED ARTICLES America South Korean workers detained in US head home as Seoul seeks support for new visa September 12, 2025 America Mexico not looking for conflict over tariff measures, president says September 12, 2025 America Qatari PM to meet Trump, other top US officials in Washington, Politico reports September 11, 2025 Most Popular FBI Director Kash Patel faces scrutiny for inaccurately saying Kirk killer had been caught September 12, 2025 Investigators in Charlie Kirk killing find weapon, release images of person of interest September 12, 2025 What we know about weapon used by suspect in Charlie Kirk’s fatal shooting September 12, 2025 South Korean workers detained in US head home as Seoul seeks support for new visa September 12, 2025 Brazil’s Bolsonaro sentenced to 27 years after landmark coup plot conviction September 12, 2025 Exclusive-‘Claims of surrender are false’: Taiwan updates security handbook wary of China threat September 12, 2025 Load more